Recombinant methods for production of serine protease inhibitors and DNA sequences
US6291662A · kind A · utility
6Cited by
30References
24Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Sep 22, 1998 |
| Grant date | Sep 18, 2001 |
| Priority date | — |
| Expiry date | Sep 22, 2018 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07K2319/02
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
A synthetic DNA sequence and its genetic equivalents are disclosed which sequences are capable, when used in a recombinant DNA method, of directing production of a serine protease inibitor protein. Recombinant DNA methods for the production of serine protease inhibitor proteins are also disclosed. These methods incorporate either the synthetic DNA sequence of the present invention or natural DNA sequences isolated from human cDNA or genomic libraries.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.